Researchers have identified a new immune function of human M cells, which can process and present gluten antigens, suggesting a potential link to celiac disease. This discovery sheds light on gut immunity and may support future research into celiac disease diagnosis or treatment.
The study introduces a synthetic, animal-free gel that enables the long-term growth of 3D organoids, overcoming limitations of traditional animal-derived gels. The PIC–invasin gel offers robustness, consistency, and potential for widespread use in research and clinical settings.
Cells on the intestinal surface are replaced every few days due to pulling forces that determine which cells are weakest and need to leave. Weakened cells are removed from the intestine due to disrupted tug-of-war behavior, leading to inflammation and disease.
Researchers have found a promising new method for gene therapy by bringing dormant genes closer to enhancer switches on the DNA. This 'delete-to-recruit' strategy has potential for treating genetic diseases such as sickle cell disease and beta-thalassemia, offering an alternative to expensive current treatments.
Scientists discovered that specific gut cells, BEST4/CA7+ cells, regulate electrolyte and water balance in response to bacterial toxins. These cells greatly increase in number when exposed to interferon-γ, presenting a potential target for therapies.
Researchers developed a new microscopy technique to observe how ribosomes function in cells. They discovered that ribosomes help each other when encountering difficulties, a process they refer to as 'ribosome cooperativity'. This finding provides insights into how proteins are made and offers a tool for better studying mRNA translation.
A zebrafish protein, Hmga1, has been found to unlock dormant genes for heart repair in mice. The discovery could lead to regenerative therapies to prevent heart failure in humans.
Researchers have developed a new way to grow organoids using Invasin, a protein produced by bacteria, mimicking the original organ with its variety of cell types. This study provides an affordable, standardized and animal-free alternative to currently used methods.
Scientists have developed a new organoid that includes all three key cell types in the pancreas, allowing for a clearer understanding of its early development. The research discovered a new stem cell type that can develop into these cells, and found differences between human and mouse pancreatic development.
Researchers at the Hubrecht Institute have mapped the activity of DNA repair proteins in individual human cells, discovering unique and sometimes rare ways to repair DNA damage. These proteins organize into 'hubs' where multiple damaged DNA regions come together, making the process more efficient.
The study found that DNA packaging sends signals through an unusual pathway, affecting cell division and growth. Chromatin acts as a guide, telling the cell how to read and use the information in the DNA.
A team of researchers has developed strategies to identify regulators of intestinal hormone secretion, which could lead to new treatments for metabolic and gut motility disorders. They used human organoids to study the function of 'nutrient sensors' on hormone-producing cells in the gut.
Researchers have found that variability in when and how cells divide during embryo development leads to more optimal arrangements of cells, promoting robust tissue formation. This study challenges traditional views on the role of cell division variability in embryonic development.
Researchers from the Hubrecht Institute found that tuft cells can proliferate and generate new epithelial cell types, restoring damaged gut tissue. This discovery may have important implications for regenerative medicine.
Researchers from the Kind Group have gained new insights into the mechanism behind the spatial organization of DNA within cells of early embryos. They found that DNA regions near the nuclear edge are repelled by a specific protein modification, leading to an unusual organization that enables cells to differentiate into various types.
A groundbreaking study has revealed that the centromere consists of two subdomains, which play a crucial role in ensuring proper chromosome segregation during cell division. This discovery provides new insights into the mechanisms underlying erroneous divisions in cancer cells.
Researchers have developed a new organoid model to study the thymus and its function in training T cells. The model enables long-term culture of TECs, which could lead to new insights into treating patients with impaired thymus function.
A new link has been discovered between FBXW7 mutations and EGFR signaling activity in colorectal cancer. The study found that the mutated form of the FBXW7 gene could no longer degrade the EGFR protein, leading to increased signaling activity and a decreased response to anti-EGFR treatment.
The Organoid group at the Hubrecht Institute produced the first organoid model of the human conjunctiva, which functions like real human conjunctiva. The researchers discovered a new cell type called tuft cells that become more abundant under allergy-like conditions and play a role in eye's reaction to allergies.
Researchers have developed a new model for studying pulmonary neuroendocrine tumors, which may indicate that patients with EGF-dependent NETs can be treated with EGF receptor inhibitors. This discovery provides a promising route of treatment for aggressive pulmonary NETs.
Researchers developed a gene therapy approach to target the root cause of ACM, restoring plakophilin-2 levels and improving heart function. Clinical trials starting in 2024 aim to explore this approach in patients with PKP2 mutations.
Researchers developed a new technique called MAbID to study multiple mechanisms of gene regulation simultaneously, enabling the connection between different gene expression processes. This technology can be applied to various fields, including human development and disease research.
The study reveals that CENP-E binds to protein complexes, forming a scaffold for the fibrous corona's development. This discovery sheds light on errors during cell division and could contribute to cancer treatment strategies.
Researchers used gut organoids to study gut cell differentiation, identifying ZNF800 as a key regulator of enteroendocrine cells. The discovery could have implications for understanding gastrointestinal diseases and endocrine disorders.
Researchers used base editors to introduce specific combinations of activating and inactivating mutations into healthy organoids, creating realistic models for various types of cancer. This allows for further investigation into the development and treatment of cancer, with potential applications including testing new drugs.
Researchers have discovered a key mechanism behind zebrafish heart regeneration, which has been found to be evolutionary conserved in human and mouse heart muscle cells. The study suggests that manipulating this mechanism could lead to the development of new therapies for cardiovascular diseases.
Researchers developed a biobank of head and neck cancer organoids to validate biomarkers and predict treatment responses. The study found that organoid responses matched patient outcomes, suggesting potential for personalized therapies.
Researchers discovered ERK signalling is a crucial switch between scarring and regeneration, with prolonged activation promoting regenerative success. Modulating ERK activity could potentially stimulate regeneration in clinical settings.
Researchers found that a plakophilin-2 mutation leads to increased desmosomal protein degradation in ACM hearts, causing structural and functional changes. Studying human heart samples and mice models confirmed the role of protein degradation in ACM development.
Researchers identified a new mutation in the desmoplakin gene that leads to cardiac disease arrhythmogenic cardiomyopathy (ACM). The mutation affects heart muscle cell connections and ion channel function, highlighting the importance of desmosomes in maintaining healthy heart function.
Researchers created human organoid models of fatty liver disease to shed light on drug responses and disease biology. The models identified a common mechanism for effective drugs that block lipid generation from sugars, suggesting personalized medicine applications.
New insights into the processing of hormones in the human gut reveal dozens of peptides regulating appetite, bowel movement, and insulin secretion. By studying human intestinal organoids, researchers characterized potentially novel gut hormones, including glucagon, and explored its role in human physiology.
Researchers developed optimized human small intestinal organoids with mature Paneth cells, mimicking the original human intestine. The discovery highlights the importance of Interleukin-22 in activating Paneth cells, which helps prevent infections and maintain barrier function.
Researchers discovered a new gene, ZBTB11, that drives heart muscle cell degeneration in arrhythmogenic cardiomyopathy. The gene's activity induces damage to neighboring heart cells, a key process in the disease.
Researchers applied scRNA-seq to study hypertrophic cardiomyopathy, identifying novel regulatory interactions and genes driving disease-related swelling. This knowledge can be used to develop new drugs that target underlying causes, reducing disease progression.
Researchers developed a new method, EpiDamID, to analyze single cells and determine the location of modified proteins around which DNA is wrapped. This technique helps understand how PTMs affect gene expression and has implications for early development and disease research.
Recent studies found that intestinal cells can change specializations in response to BMP signaling. This process, called zonation, is crucial for the proper functioning of the gut. Researchers used organoids and mouse models to confirm this discovery, which may lead to new treatments for metabolic diseases.
Researchers have created the first patient-specific zebrafish model for arrhythmogenic cardiomyopathy (ACM), a heart disease caused by a genetic mutation. The model recapitulates the human form of ACM, including fat accumulation in the heart and changes in calcium levels, and shows promise for relieving symptoms.
Researchers have established an organoid biobank to search for genes essential for SARS-CoV-2 replication and spread. The study identified TMPRSS2 as a potential therapeutic target for the coronavirus, with specific inhibitors recently developed.
Researchers from the Hubrecht Institute have successfully corrected mutations that cause cystic fibrosis in cultured human stem cells using prime editing. The technique is safer than CRISPR/Cas9 and shows promise for application in patients, potentially leading to a cure or prevention of genetic diseases.
Computer simulations reveal that DNA sequence and histone tails play crucial roles in nucleosome breathing, a motion essential for gene expression regulation. The findings provide unprecedented insights into the mechanisms that control chromatin dynamics.
Researchers have created the first patient-derived organoid model for cervical cancer, allowing them to study human papillomavirus (HPV) and its impact on cervical tissue. The model's success holds promise for advancing research into cervical biology and associated diseases.
Scientists have successfully grown miniature human tear glands in a lab, allowing them to study how cells produce tears and what goes wrong. The model has promise for identifying new treatments for patients with tear gland disorders, such as dry eye disease.
Researchers identified rare cell types in esophagus, stomach and small intestine using scRNA-seq. They found a cell type responsible for water secretion in humans, linking it to cystic fibrosis.
Researchers from the Hubrecht Institute mapped the recovery of the heart after a heart attack, highlighting the importance of cardiomyocyte communication in forming scar tissue. The study provides new insights into the complex process of heart recovery, shedding light on potential therapeutic targets to improve outcomes.
Researchers have developed a new technique called VIRIM that allows for real-time imaging of virus infections, enabling the tracking of viral replication and protein production. This breakthrough could lead to more targeted treatments for viral infections, such as SARS-CoV-2.
Researchers have identified a fungal compound, cercosporamide, that inhibits BMP receptors, which are overactive in certain diseases. This finding offers new possibilities for treating conditions like Fibrodysplasia ossificans progressiva.
The study mapped the molecular characteristics of the aortic microenvironment where Hematopoietic Stem Cells (HSCs) form. Researchers identified conserved regulators, such as ADM and RAMP2, involved in HSC production in vivo.
A study by the Hubrecht Institute found that oviduct cells are more prone to develop into tumors than ovarian surface epithelium cells. This suggests a possible shift in treatment approach, with earlier removal of fallopian tubes considered as a preventive measure for high-risk patients.
The study reveals 10 major hormone types and their interactions, shedding light on how enteroendocrine cells sense food and regulate hunger and satiety. The discovery offers new avenues for treating diseases like type 2 diabetes and obesity.